Increased glucose metabolism detected by 18FDG PET imaging in unsuspected extra-temporal vessels locations of Horton's disease. Clinical observations and review of literature;Maladie de Horton et atteintes artérielles extratemporales: Utilité de la tomographie par émission de positons au 18FDG. À propos de trois observations et d'une revue de la littérature

Revue de Medecine Interne

Volumn 23, Issue 7, 2002, Pages 584-591

  Belhocine, T ^a   Kaye, O ^a   Delanaye, P ^a   Corman, V ^a   Baghaie, M ^a   Deprez, M ^a   Daenen, F ^a   De Barsy, C ^a   Beckers, C ^a   Gomez, P ^a   Hustinx, R ^a   Foidart Willems, J ^a   Demonty, J ^a   Malaise, M ^a   Rigo, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

18F Fluorodeoxyglucose; Giant cell arteritis; Horton's disease; Positron Emission Tomography; Vasculitis

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18;

ABDOMINAL AORTA; ADULT; AGED; AORTA ARCH; ARTICLE; ASCENDING AORTA; CAROTID ARTERY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC VALUE; FEMALE; FEMORAL ARTERY; GIANT CELL ARTERITIS; GLUCOSE METABOLISM; HUMAN; HYPERMETABOLISM; ILIAC ARTERY; INFLAMMATION; MALE; POSITRON EMISSION TOMOGRAPHY; SUBCLAVIAN ARTERY; TEMPORAL ARTERITIS; THORACIC AORTA; WHOLE BODY SCINTISCANNING;

EID: 0036318086     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(02)00620-3     Document Type: Article

References (39)

1. Maladie de Horton. Anatomie pathologique, diagnostic, évolution, traitement
2. Aortic and extracranial large vessel giant cell arteritis: A review of 72 cases with histopathologic documentation
3. Atteinte des gros troncs artériels dans la maladie de Horton
4. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study
5. Aortic dissection in giant-cell arteritis
6. On the origin of cancer cells
7. FDG accumulation and tumour biology
8. Giant cell arteritis as a cause of death
9. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy
10. Giant cell arteritis of the legs. Clinical isolation of severe disease with gangrene and amputations
11. Large artery involvement in giant cell (temporal) arteritis
12. Arteritis of the arms
13. Oncological applications of FDG PET Imaging
14. Oncological applications of emission tomography with fluorine-18 fluorodeoxyglucose
15. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: Preliminary results
16. Infection imaging using whole-body FDG-PET
17. F-18-FDG uptake in tuberculosis
18. Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography
19. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis
20. Periaortitis and aortic dissection due to Wegener's granulomatosis
21. FDG-PET finding in early-phase Takayasu arteritis
22. Imaging of giant cell arteritis: Evidence of splenic involvement using FDG positron emission tomography
23. Detection of vaculitis by FDG-PET using MCD
24. Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta
25. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis
26. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography
27. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch
28. Pitfalls in oncologic diagnosis with FDG-PET imaging: Physiologic and benign variants
29. Whole-body PET: Physiological and artifactual fluorodeoxyglucose accumulations
30. 18F-FDG ([F-18]-2-fluoro-2-deoxy-D-glucose) injection for imaging of tumor reflecting glucose metabolism-results of preclinical studies
31. F-18 FDG Uptake in the Large Arteries. A New Observation
32. Metabolic fate of glucose in vascular smooth muscle during contraction induced by norepinephrine
33. Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose (FDG)
34. Biopsie d'artère temporale
35. Giant cell arteritis: New concepts in pathogenesis and implications for management
36. Absorbed dose estimates in positron emission tomography studies based on the administration of 18F-labeled radio-pharmaceuticals
37. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies
38. Toxicity and radiation dosage of 2-(18F)-2-desoxy-D-glucose in positron emission tomography
39. Classification/diagnostic criteria for GCA/PMR